Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study
Joachim Spranger,Anja Kroke,Matthias Möhlig,Kurt Hoffmann,Manuela M. Bergmann,Michael Ristow,Heiner Boeing,Andreas Pfeiffer +7 more
TL;DR: The data suggest that the pattern of circulating inflammatory cytokines modifies the risk for type 2 diabetes, and strongly support the hypothesis that a subclinical inflammatory reaction has a role in the pathogenesis of type 2abetes.
read more
Abstract: A subclinical inflammatory reaction has been shown to precede the onset of type 2 (non-insulin-dependent) diabetes. We therefore examined prospectively the effects of the central inflammatory cytokines interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha) on the development of type 2 diabetes. We designed a nested case-control study within the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study including 27,548 individuals. Case subjects were defined to be those who were free of type 2 diabetes at baseline and subsequently developed type 2 diabetes during a 2.3-year follow-up period. A total of 192 cases of incident type 2 diabetes were identified and matched with 384 non-disease-developing control subjects. IL-6 and TNF-alpha levels were found to be elevated in participants with incident type 2 diabetes, whereas IL-1beta plasma levels did not differ between the groups. Analysis of single cytokines revealed IL-6 as an independent predictor of type 2 diabetes after adjustment for age, sex, BMI, waist-to-hip ratio (WHR), sports, smoking status, educational attainment, alcohol consumption, and HbA(1c) (4th vs. the 1st quartile: odds ratio [OR] 2.6, 95% CI 1.2-5.5). The association between TNF-alpha and future type 2 diabetes was no longer significant after adjustment for BMI or WHR. Interestingly, combined analysis of the cytokines revealed a significant interaction between IL-1beta and IL-6. In the fully adjusted model, participants with detectable levels of IL-1beta and elevated levels of IL-6 had an independently increased risk to develop type 2 diabetes (3.3, 1.7-6.8), whereas individuals with increased concentrations of IL-6 but undetectable levels of IL-1beta had no significantly increased risk, both compared with the low-level reference group. These results were confirmed in an analysis including only individuals with HbA(1c) <5.8% at baseline. Our data suggest that the pattern of circulating inflammatory cytokines modifies the risk for type 2 diabetes. In particular, a combined elevation of IL-1beta and IL-6, rather than the isolated elevation of IL-6 alone, independently increases the risk of type 2 diabetes. These data strongly support the hypothesis that a subclinical inflammatory reaction has a role in the pathogenesis of type 2 diabetes.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Gene expression of inflammatory cytokines in peripheral leukocytes in db/db mice rose with progression of diabetes.
TL;DR: Together, inflammatory cytokine/cytokine-like factor mRNA levels in peripheral leukocytes were associated with progression of diabetes in db/db mice.
3
Effect of Non-Surgical Periodontal Therapy on Systemic Inflammatory Markers, Glycemic Status and Levels of Proteinuria in Type 2 Diabetic and Non-Diabetic Patients With Chronic Periodontitis
Gopalakrishnan Sundaram,T. Ramakrishnan,Sneha G. Krishnan,Keerthi Narayan,Siva Shankar,G. Kanimozhi +5 more
TL;DR: Results of the study showed improved glycemic control and a reduction in systemic inflammatory markers and proteinuria after performing non-surgical periodontal treatment in patients with type 2 diabetes.
3
Obesity, infl ammation, and the gut microbiota
Amanda J. Cox,A J Cox,Nicholas P. West,Allan W. Cripps +3 more
- 01 Jan 2015
TL;DR: Evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of infl ammation in obesity is provided.
3
7-Ketocholesterol accelerates pancreatic β-cell senescence by inhibiting the SIRT1/CDK4–Rb–E2F1 signaling pathway
TL;DR: The role of 7-ketocholesterol in pancreatic β-cell senescence and its underlying molecular mechanism in MIN6 cells was investigated in this article , which showed that 7-KC can significantly increase SA-β-galactosidase activity, promoted G0/G1 arrest, DNA damage, and interleukin-1β expression.
3
Host characteristics associated with serologic inflammatory biomarkers in women
TL;DR: In this article , the authors conducted a cross-sectional study within the California Teachers Study prospective cohort, among female participants who had completed a questionnaire that asked about their health behaviors (e.g., diabetes, physical activity, body mass index, medication use) and who had donated blood within a year of their questionnaire.
3
References
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Cem Gabay,Irving Kushner +1 more
TL;DR: A large number of changes, distant from the site or sites of inflammation and involving many organ systems, may accompany inflammation, and the mechanisms mediating them are becoming better understood.
6.8K
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
TL;DR: Elevated levels of CRP and IL-6 predict the development of type 2 DM, and data support a possible role for inflammation in diabetogenesis.
4.6K
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Frank B. Hu,JoAnn E. Manson,Meir J. Stampfer,Graham A. Colditz,Simin Liu,Caren G. Solomon,Walter C. Willett +6 more
TL;DR: The hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle is supported.
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
Minsheng Yuan,Nicky Konstantopoulos,Jongsoon Lee,Lone Hansen,Zhi-Wei Li,Michael Karin,Steven E. Shoelson +6 more
TL;DR: It is shown that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling and identifies the IKKβ pathway as a target for insulin sensitization.
2K
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
TL;DR: NIDDM is associated with an elevated acute-phase response, particularly in those with features of syndrome X, and abnormalities of the innate immune system may be a contributor to the hypertriglyceridaemia, low HDL cholesterol, hypertension, glucose intolerance, insulin resistance and accelerated atherosclerosis of NIDDM.